Abstract
IntroductionFactors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. MethodologyWe performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. ResultsThe proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. DiscussionNo tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival.
Original language | English |
---|---|
Article number | 751110 |
Number of pages | 7 |
Journal | Frontiers in medicine |
Volume | 8 |
DOIs | |
Publication status | Published - 9 Feb 2022 |
Keywords
- cancer immunity
- pancreatic cancer
- neoantigen and shared-antigen vaccine
- mutation-genetics
- chromosomal instability disorders
- NEURAL-NETWORKS